Search Results 901-910 of 17566 for Detox

1. A Study of the ExAblate UF V2 System for the Treatment of Symptomatic Uterine Fibroids - Mayo Clinic

   ExAblate delivers a pulse of focused ultrasound energy, or sonication, to the targeted tissue. In this particular study, the targeted tissue is uterine fibroids ...

2. Technologies to Increase In-Seat Movement to Prevent Sitting Acquired Pressure Injuries in Wheelchair Users - Mayo Clinic

   The purpose of this aim of the project is to assess the effectiveness of two seating pressure systems for changing the movement behavior of wheelchair users who ...

3. A Study to Establish A Sorin Universal REgistry on Aortic Valve Replacement - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

4. A Clinical Study To Investigate The Efficacy And Safety Of An Investigational Combination Therapy With BNT324 And BNT327 In Patients With Advanced Lung Cancer - Mayo Clinic

   The purpose of this study is to determine the RP2D of BNT324 in combination with BNT327 by assessing the safety and tolerability in participants with advanced ...

5. A Phase 2 Study to See if Simtuzumab (GS-6624) is Safe and Works in Idiopathic Pulmonary Fibrosis (IPF) - Mayo Clinic

   The purpose of this study is to determine if Simtuzumab (GS-6624) is safe and effective in treating Idiopathic Pulmonary Fibrosis. Participation eligibility.

6. The Use of the Cerebral Oximetry for Patients Undergoing Dynamic Computed Tomography Myelography under General Anesthesia - Mayo Clinic

   The purpose of this study is to: Prospectively characterize the dynamic systemic hemodynamic changes that occur during dynamic CT myelography. Prospectively ...

7. Dose Escalation and Expansion Study of GSK525762 in Combination With Fulvestrant in Subjects With Estrogen Receptor Positive (ER+) Breast Cancer - Mayo Clinic

   This is a combination Phase I and Phase II study, with an aim to evaluate the combination of GSK525762 and fulvestrant in women with advanced or metastatic ER+ ...

8. Safety and Pharmacology of SNX-5422 Plus Everolimus in Subjects with Neuroendocrine Tumors - Mayo Clinic

   Study is designed to determine the maximum tolerated dose (MTD) of SNX-5422 when given in combination with everolimus. Participation eligibility. Participant ...

9. A Study to Evaluate the Safety and Effectiveness of Allogeneic Mesenchymal Precursor Cells for the Treatment of Heart Failure - Mayo Clinic

   The primary objective of this study is to determine whether transendocardial delivery of allogeneic human bone marrow-derived MPCs (rexlemestrocel-L) is ...

10. A Study To Investigate ALE.P03 As Monotherapy In Adult Patients With Selected Advanced Or Metastatic CLDN1+ Solid Tumors - Mayo Clinic

    The purpose of this study is to evaluate the safety, tolerability, pharmacokinetic, pharmacodynamic, preliminary anti-tumor activity, and to determine the ...